Co-Diagnostics, Inc. (CODX)
4.88
+0.38
(+8.44%)
USD |
NASDAQ |
Jun 10, 16:00
4.80
-0.08
(-1.64%)
Pre-Market: 08:40
Co-Diagnostics EPS Diluted (Quarterly) : -4.056 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -4.056 |
| December 31, 2025 | -12.29 |
| September 30, 2025 | -4.661 |
| June 30, 2025 | -7.004 |
| March 31, 2025 | -0.2351 |
| December 31, 2024 | -10.01 |
| September 30, 2024 | -0.318 |
| June 30, 2024 | -0.2523 |
| March 31, 2024 | -0.312 |
| December 31, 2023 | -0.4695 |
| September 30, 2023 | -0.2037 |
| June 30, 2023 | -0.3066 |
| March 31, 2023 | -0.1952 |
| December 31, 2022 | -0.7095 |
| September 30, 2022 | -0.0434 |
| June 30, 2022 | -0.0827 |
| March 31, 2022 | 0.3375 |
| December 31, 2021 | 0.2497 |
| September 30, 2021 | 0.3831 |
| June 30, 2021 | 0.329 |
| March 31, 2021 | 0.2633 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.4485 |
| September 30, 2020 | 0.5315 |
| June 30, 2020 | 0.5147 |
| March 31, 2020 | -0.0467 |
| December 31, 2019 | -0.10 |
| September 30, 2019 | -0.1009 |
| June 30, 2019 | -0.079 |
| March 31, 2019 | -0.0852 |
| December 31, 2018 | -0.152 |
| September 30, 2018 | -0.1328 |
| June 30, 2018 | -0.11 |
| March 31, 2018 | -0.11 |
| December 31, 2017 | -0.1222 |
| September 30, 2017 | -0.33 |
| June 30, 2017 | -2.70 |
| March 31, 2017 | -0.5207 |
| December 31, 2016 | -0.3876 |
| September 30, 2016 | -0.332 |
| June 30, 2016 | -0.3266 |
| March 31, 2016 | -0.3769 |
| December 31, 2015 | -0.3577 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fractyl Health, Inc. | 0.0582 |
| Spectral AI, Inc. | -0.1074 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| INmune Bio, Inc. | -0.2034 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.14M |
| Revenue (Quarterly) | 0.146M |
| Total Expenses (Quarterly) | 9.286M |
| Enterprise Value | 11.38M |
| Gross Profit Margin (Quarterly) | -207.7% |
| Profit Margin (Quarterly) | -6.26K% |
| Earnings Yield | -574.0% |
| Normalized Earnings Yield | -444.70 |